- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Astec LifeSciences saw improved financial results. Total income rose to ₹453.22 Cr, achieving EBITDA break-even for the year from a prior loss. Net loss significantly reduced. Domestic sales jumped 40.6%, exports grew 6.7%. CDMO now drives 52% of sales. A Rights Issue successfully raised ₹249.35 Cr. New Chairperson and Executive Director appointments were announced.